The overexpression of the marker gene RGS-5 and IL-6 stimulation of tumor-derived pericytes mediate CD4+ T-cell anergy in vitro, elicited by the upregulation of anergy-related factors (dgkα, erg2, and erg3). The gene discussed is IL6; the disease is neoplasm.